Caredx, inc. (CDNA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities:
Net loss

-5,823

-4,777

-1,813

-7,847

-7,531

-3,755

-19,970

-14,062

-8,994

-31,629

-14,287

-4,035

-5,609

-15,709

-3,801

-10,494

-9,752

-4,762

-3,488

-3,185

-2,272

-5

1,213

877

-1,304

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

4,259

5,407

5,965

4,992

6,053

2,060

1,861

2,511

706

428

430

495

391

487

699

366

446

313

336

412

280

185

165

137

48

Amortization of deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

2

12

15

16

15

56

30

29

701

3

6

17

Revaluation of common stock warrant liability to estimated fair value

-405

333

4,346

-1,351

-3,009

1,562

-17,093

-8,768

1,321

-26,218

-8,599

1,067

4,128

1,529

1,386

-3,165

0

-

-

-

-

-

-269

-245

528

Amortization of inventory fair market value adjustment

-

-

-

-

-

10

35

25

164

89

159

138

32

1,437

1,513

1,225

0

-

-

-

-

-

-

-

-

Depreciation and amortization

1,619

1,683

1,460

1,219

1,161

1,176

1,014

986

1,039

987

919

887

934

725

1,098

836

261

221

217

193

165

158

132

116

106

Amortization of right-of-use assets

612

-

-

-

372

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of contingent consideration to estimated fair value

190

210

0

0

0

0

0

873

144

871

594

-64

-221

-34

-112

-97

-213

330

-345

142

-253

37

-1,276

0

0

Loss on conversion of JGB Debt to shares of common stock

-

-

-

-

-

-

0

0

2,806

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount and noncash interest expense

-

-

-

-

-

44

56

48

2,084

680

1,003

1,142

627

-455

298

15

41

43

-246

43

407

7

443

196

153

Non-cash goodwill impairment

-

-

-

-

-

-

-

-

-

0

0

0

1,958

13,021

0

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-2,346

4,859

1,860

3,174

2,782

137

1,550

1,674

606

-207

164

-424

576

-1,737

-292

837

145

126

535

-88

-893

938

24

-368

-177

Inventory

1,343

-57

776

179

372

-5

-25

-137

-196

-563

-210

218

-470

-167

-89

-65

-171

-49

84

-43

88

190

-118

-111

207

Prepaid and other assets

545

1,395

-785

-322

541

328

-122

-214

510

-147

42

-56

245

291

-445

-282

-563

430

285

-72

180

-151

-1,691

582

1,570

Operating leases liabilities, net

-344

-418

-1,018

57

-475

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

1,757

348

-2,282

3,734

-449

695

-1,058

-640

835

92

-222

40

382

370

-654

-1,156

820

-302

907

-358

242

306

-919

960

163

Accrued compensation

-5,914

2,077

2,919

2,368

-4,249

915

2,690

2,044

-1,358

673

878

379

-865

153

785

797

-758

174

141

756

-389

281

213

364

-560

Accrued royalties

-

-

-

-

-

-

-

-

-

-

-

-

-

-47

50

28

-10

-10

-16

13

14

-56

-3,228

721

0

Accrued and other liabilities

48

551

1,270

1,006

202

289

357

-571

644

-376

-147

-1,092

382

-2,698

440

-247

2,400

541

425

78

196

43

-1,796

-546

2,663

Change in deferred revenue

-

-

-

-

-

-

-

-

-

-

-10

-10

-2

-

-

-

-

-

-

-

-

-

-

-

-

Change in deferred taxes

322

126

637

252

265

439

276

545

347

1,406

140

271

271

393

947

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-3,055

-1,083

605

3,576

-5,867

1,998

399

-1,886

-4,518

-2,150

-2,220

-3,196

-6,741

-3,061

-1,203

-6,067

-6,192

-3,976

-3,029

-1,733

-1,014

-722

-3,661

853

180

Purchase of property and equipment, net

1,704

-

409

18

543

-

614

399

62

-

6

26

68

-78

351

167

109

76

390

369

364

400

169

145

19

Net cash used in investing activities

-1,704

-1,342

-3,515

-17,179

-543

-960

-614

-5,601

-754

-5,036

-975

-26

-68

73

-351

-20,734

-109

-76

-390

-369

-364

-594

-199

-521

-19

Financing activities:
Perceptive term loan issuance costs

-

-

-

-

-

-

-

-

584

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock under employee stock purchase plan

358

0

419

0

341

255

0

0

32

1

49

0

44

0

129

0

175

-

-

-

-

-

-

-

-

Taxes paid related to net share settlement of restricted stock units

1,507

149

29

1,597

2,378

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in short-term credit facility

-

-

-

-

-

0

0

-452

-225

-581

405

176

0

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash collateral for debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

300

0

-5

5

100

0

10,476

499

25

954

35

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

155

308

476

1,404

1,365

891

410

99

80

262

0

0

0

10

0

3

6

1

3

31

11

14

0

1

4

Restricted cash on operating leases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Proceeds from debt, net of issuance costs

-

-

-

-

-

-

-

-

-

0

0

0

24,002

-

-

-

-

0

0

0

15,625

-4,982

0

4,982

0

Principal payments on debt and finance lease obligations

45

44

44

42

42

16,692

48

9,716

1,633

1,107

381

-44

12,915

1,774

1,938

216

16

15

-273

20

11,704

1,298

1,403

1,371

456

Net cash used in financing activities

-735

82

746

-272

-688

37,312

10,198

5,076

-2,318

17,920

108

220

11,131

-2,134

6,686

20,210

165

-14

479

11

3,932

-1,301

35,036

2,703

-452

Effect of exchange rate changes on cash and cash equivalents

-552

-356

-382

-24

-87

64

-12

-67

17

210

-40

-81

17

111

-11

-17

0

-

-

-

-

-

-

-

-

Net decrease in cash, cash equivalents and restricted cash

-6,046

-2,699

-2,546

-13,899

-7,185

38,414

9,971

-2,478

-7,573

10,944

-3,127

-3,083

4,339

-5,011

5,121

-6,608

-6,136

-4,066

-2,940

-2,091

2,554

-2,617

31,176

3,035

-291

Deferred purchase consideration

-

-

-

-

-

-

-

-

-

-1,064

0

46

1,018

-

-

-

-

-

-

-

-

-

-

-

-

Allenex [Member]
Acquisition of Allenex AB

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Allenex AB [Member]
Acquisition of business and noncontrolling interests, net of cash acquired

-

-

-

-

-

-

-

-

692

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conexio
Contingent payments related to acquisition

0

33

76

64

52

54

80

78

13

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-